Bristol-Myers Squibb Company has selected Laboratory Corporation of America Holdings (LabCorp) Clinical Trials for global central laboratory services and biomarker testing services for a period of five years.
Subscribe to our email newsletter
LabCorp chief medical officer Dr. Mark Brecher said, "We are excited to expand our relationship with Bristol-Myers Squibb to provide a more flexible and integrated approach to laboratory testing services in support of their innovative clinical development pipeline."
Earlier, Bristol-Myers’ early and late-stage clinical development programs were supported by LabCorp’s global central lab, biomarker and specialty testing capabilities.